The Synthetic Biology Group is interested in applying genetic engineering technologies to better understand pathogenic bacteria and fight them.
The rise of emerging pathogens and antibiotic resistances is becoming a major public health issue. Using engineering principles we are creating new strategies to quickly decipher the mechanisms of bacterial virulence and provide tools to specifically kill antibiotic resistant and virulent bacteria.
